Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Neoplasms 2Malnutrition 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Thrombosis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sexuality 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Radiation Injuries 1Protein Metabolism 1Polycystic Ovary Syndrome 1Pain 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Meningioma 1Hemorrhage 1Glioblastoma 1Erectile Dysfunction 1Disease 1Diabetes Insipidus 1Brain Neoplasms 1

Interventions

Metformin 139Clomiphene 44Letrozole 36Inositol 28Folic Acid 17Exercise 17Progesterone 16Ethinyl Estradiol 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Chorionic Gonadotropin 10Triptorelin Pamoate 9Tablets 9Spironolactone 8Diet 8Cholecalciferol 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Menotropins 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7drospirenone 6Ovidrel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Polycystic Ovary Syndrome × Arginine × Clear all
NCT06405243 2024-05-08

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

Beni-Suef University

Phase 3 Unknown
100 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡